HK1204481A1 - Method for in vitro diagnosis or prognosis of colon cancer - Google Patents

Method for in vitro diagnosis or prognosis of colon cancer

Info

Publication number
HK1204481A1
HK1204481A1 HK15104986.1A HK15104986A HK1204481A1 HK 1204481 A1 HK1204481 A1 HK 1204481A1 HK 15104986 A HK15104986 A HK 15104986A HK 1204481 A1 HK1204481 A1 HK 1204481A1
Authority
HK
Hong Kong
Prior art keywords
prognosis
colon cancer
vitro diagnosis
vitro
diagnosis
Prior art date
Application number
HK15104986.1A
Other languages
English (en)
Chinese (zh)
Inventor
弗朗索瓦．馬萊
娜塔莉．米尼耶
菲力浦．佩羅
Original Assignee
Biomrieux
Hospices Civils Lyon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomrieux, Hospices Civils Lyon filed Critical Biomrieux
Publication of HK1204481A1 publication Critical patent/HK1204481A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK15104986.1A 2011-12-20 2015-05-26 Method for in vitro diagnosis or prognosis of colon cancer HK1204481A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1162049A FR2984360B1 (fr) 2011-12-20 2011-12-20 Procede pour le diagnostic ou le pronostic in vitro du cancer du colon
PCT/FR2012/052954 WO2013093315A2 (fr) 2011-12-20 2012-12-17 Procede pour le diagnostic ou le pronostic, in vitro, du cancer du colon

Publications (1)

Publication Number Publication Date
HK1204481A1 true HK1204481A1 (en) 2015-11-20

Family

ID=47505252

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104986.1A HK1204481A1 (en) 2011-12-20 2015-05-26 Method for in vitro diagnosis or prognosis of colon cancer

Country Status (9)

Country Link
US (1) US11453916B2 (ko)
EP (1) EP2794913B1 (ko)
JP (1) JP6357420B2 (ko)
KR (1) KR102046839B1 (ko)
CN (2) CN104185685A (ko)
ES (1) ES2652497T3 (ko)
FR (1) FR2984360B1 (ko)
HK (1) HK1204481A1 (ko)
WO (1) WO2013093315A2 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2984362B1 (fr) * 2011-12-20 2017-11-24 Biomerieux Sa Procede pour le diagnostic ou le pronostic in vitro du cancer du poumon
JP6963009B2 (ja) * 2016-05-19 2021-11-05 オンコスカー エルエルシーOncoscar Llc 臨床的に難治性の悪性腫瘍の診断及び治療標的化の方法
CN106676191B (zh) * 2017-03-03 2019-06-21 中日友好医院 一种用于结肠腺癌的分子标志物
CN107012213A (zh) * 2017-03-24 2017-08-04 南开大学 结直肠癌的生物标记物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
EP0730663B1 (en) * 1993-10-26 2003-09-24 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
ATE440141T1 (de) * 1996-11-26 2009-09-15 Bio Merieux Virales material und mit multipler sklerose assoziierte nukleotidfragmente mit diagnostischen,prophylaktischen und therapeutischen verwendungen
EP2336368A1 (en) * 2000-12-07 2011-06-22 Novartis Vaccines and Diagnostics, Inc. Endogenous retroviruses up-regulated in prostate cancer
EP1338606A1 (en) * 2002-02-22 2003-08-27 Magnus Von Knebel Doeberitz Nucleic Acid encoding an HERV-H polypeptide for diagnosing colorectal cancer
EP2340851A4 (en) * 2008-09-18 2012-09-26 Univ Keio DIAGNOSTIC METHOD AND THERAPEUTIC METHOD FOR CANCER
CN103003444B (zh) 2010-06-08 2016-04-27 生物梅里埃公司 用于结肠直肠癌预后的方法和试剂盒
FR2984361B1 (fr) * 2011-12-20 2017-11-24 Biomerieux Sa Procede pour le diagnostic ou le pronostic in vitro du cancer du testicule
FR2984364A1 (fr) * 2011-12-20 2013-06-21 Biomerieux Sa Procede pour le diagnostic ou le pronostic in vitro du cancer de l'ovaire

Also Published As

Publication number Publication date
FR2984360B1 (fr) 2017-11-24
CN104185685A (zh) 2014-12-03
KR20140109958A (ko) 2014-09-16
WO2013093315A3 (fr) 2013-10-24
ES2652497T3 (es) 2018-02-02
EP2794913A2 (fr) 2014-10-29
KR102046839B1 (ko) 2019-11-20
CN110904230A (zh) 2020-03-24
JP2015506165A (ja) 2015-03-02
WO2013093315A2 (fr) 2013-06-27
EP2794913B1 (fr) 2017-09-20
FR2984360A1 (fr) 2013-06-21
US11453916B2 (en) 2022-09-27
JP6357420B2 (ja) 2018-07-11
US20140349857A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
IL276488B (en) A method for predicting breast cancer prognosis
HK1203091A1 (en) Methods for diagnosis of lung cancer
IL228738A0 (en) Antibodies for cancer treatment
EP2691547A4 (en) GENE EXPRESSION PREDICTORS FOR CANCER PROSPECTS
EP2625292A4 (en) KREBSBIOMARKER
HK1259001A1 (zh) 癌症的預後和診斷方法
EP2698634A4 (en) BIOMARKER FOR BREAST CANCER
HK1204016A1 (en) Methods and kits for detecting subjects at risk of having cancer
GB201102014D0 (en) Method for predicting risk of developing cancer
EP2707710A4 (en) DIAGNOSIS OF CANCER
IL232493A0 (en) A method for quantifying cancer treatment
GB201012590D0 (en) Methods for diagnosing cancer
SG11201402115TA (en) Methods for diagnosis and/or prognosis of gynecological cancer
EP2880443A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECAST IN BREAST CANCER
EP2699699A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER
HK1204481A1 (en) Method for in vitro diagnosis or prognosis of colon cancer
EP2742358A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER
GB2510539B (en) Biomarkers of cancer
EP2771695A4 (en) METHOD OF DETECTION OF BREAST CANCERS
EP2707720A4 (en) DIAGNOSIS AND PROGNOSIS OF TRIPLE-NEGATIVE BREAST CANCER AND OVARY
EP2757090A4 (en) PROCESS FOR PRODUCING AN N-ACYLAMINO TRIOL
EP2709730A4 (en) TREATMENT AND PROGNOSIS OF CANCER
EP2732287A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER
EP2570813A4 (en) METHOD OF DIAGNOSIS / PROGNOSIS OF COLORECTAL CANCER
EP2728003A4 (en) METHOD FOR DIAGNOSING THE TYPE OF PANCREATIC TUMOR